Seropositive rheumatoid arthritis with dermatomyositis sine myositis, angioimmunoblastic lymphadenopathy with dysproteinemia-type T cell lymphoma, and B cell lymphoma of the oropharynx

Journal of Rheumatology

Volumn 27, Issue 4, 2000, Pages 1087-1090

  Hashefi, Mandana ^b   McHugh, Timothy R ^b   Smith, Gerald P ^b   Elwing, Terry J ^b   Burns, Richard W ^b   Walker, Sara E ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Angioimmunoblastic lymphadenopathy with dysproteinemia; Dermatomyositis; Rheumatoid arthritis; T cell lymphoma

Indexed keywords

ADULT; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; B CELL LYMPHOMA; CASE REPORT; DERMATOMYOSITIS; DYSPROTEINEMIA; FEMALE; HUMAN; HYPERGAMMAGLOBULINEMIA; LYMPH NODE BIOPSY; MALIGNANT TRANSFORMATION; OROPHARYNX CANCER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROCONVERSION; T CELL LYMPHOMA; TUMOR RECURRENCE;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BIOPSY; BLOOD PROTEIN DISORDERS; DERMATOMYOSITIS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MIDDLE AGED; OROPHARYNX;

EID: 0034082118     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Frizzera G, Moran EM, Rappaport H. Angioimmunoblastic lymphadenopathy with dysproteinemia. Lancet 1974;1:1070-6.
2. Knecht H. Angioimmunoblastic lymphadenopathy: ten years' experience and state of current knowledge. Semin Hematol 1989;26:208-15.
3. Lukes RJ, Tindle BH. Immunoblastic lymphadenopathy: a hyperimmune entity resembling Hodgkin's disease. N Engl J Med 1975;292:1-8.
4. Abruzzo LV, Schmidt K, Weiss LM, et al. B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus. Blood 1993;82:241-6.
5. Raskin RJ, Tesar JT, Lawless OJ. Polyarthritis in immunoblastic lymphadenopathy. Arthritis Rheum 1982;25:1481-5.
6. Ozoran K, Turgay M, Kinikli G, Duman M, Tolunay O, Tokgoz G. Angioimmunoblastic lymphadenopathy with disproteinemia arising in a patient with rheumatoid arthritis. Scand J Rheumatol 1995;24:58-60.
7. Kurugliak L, Zimlichman RR, Schlaeffer F, Sacks M. Immunoblastic lymphoma and thymic epithelial hyperplasia in angioimmunoblastic lymphadenopathy following gold therapy. Israel J Med Sci 1985;21:381-5.
8. Barnes BE. Dermatomyositis and malignancy. Ann Intern Med 1976;84:68-76.
9. Whitmore SE, Watson R, Rosenshein NB, Provost TT. Dermatomyositis sine myositis. Association with malignancy. J Rheumatol 1996;23:101-5.
10. Foss H, Anagnostopoulos I, Herbst H, et al. Patterns of cytokine gene expression in peripheral T-cell lympohma of angioimmunoblastic lymphadenopathy type. Blood 1995;85:2862-9.
11. Yamamura M, Honda M, Yamada Y, et al. Increased levels of interleukin-6 (IL-6) in serum and spontaneous in vitro production of IL-6 by lymph node mononuclear cells of patients with angio-immunoblastic lymphadenopathy with dysproteinemia (AILD), and clinical effectiveness of cyclosporin A. Leukemia 1996;10:1504-8.
12. Hsu S-M, Waldron JA, Fink L, et al. Pathogenic significance of interleukin-6 in angioimmunoblastic lymphadenopathy-type T-cell lymphoma. Hum Pathol 1903;24:126-31.
13. Fries JF, Bloch D, Spitz P, Mitchell DM. Cancer in rheumatoid arthritis: a prospective long-term study of mortality. Am J Med 1985;78 Suppl 1A:56-9.
14. Natkunam Y, Elenitoba-Johnson KS, Kingma DW, Kamel OW. Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases. Arthritis Rheum 1997;40:1152-6.
15. Weiss LM, Jaffe ES, Lin X-F, Chen Y-Y, Shibata D, Medeiros LJ. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 1992;7:1789-95.